Prevalence of sexually transmitted pathogens associated with HPV infection in cervical samples in a Mexican population

Journal of Medical Virology

Volumn 87, Issue 12, 2015, Pages 2098-2105

  Magaña Contreras, Mariana ^a   Contreras Paredes, Adriana ^b   Chavez Blanco, Alma ^b   Lizano, Marcela ^b   De la Cruz Hernandez, Yanira ^c   De la Cruz Hernandez, Erick ^a  

^a UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c Obstetrics and Gynecology Clinic   (Mexico)

Author keywords

Cervical neoplasia; Coinfections; Molecular diagnosis; Sexually transmitted infections

Indexed keywords

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GARDNERELLA INFECTION; GARDNERELLA VAGINALIS; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION RISK; MASS SCREENING; MEXICAN; MYCOPLASMA GENITALIUM; MYCOPLASMOSIS; PAPILLOMAVIRUS INFECTION; POPULATION RESEARCH; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; UREAPLASMA INFECTION; UTERINE CERVIX CYTOLOGY; WART VIRUS; ADOLESCENT; AGE; AGED; CLASSIFICATION; COINFECTION; COMPLICATION; GENETICS; ISOLATION AND PURIFICATION; MEXICO; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PATHOLOGY; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL NEOPLASMS; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; COINFECTION; FEMALE; GENOTYPE; HUMANS; MEXICO; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84942889126     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24278     Document Type: Article

References (46)

1. Baltazar Reyes MC, Rivera Rivera L, Cruz Valdez A, Hernandez Giron CA. 2005. Prevalence of sexually transmitted infections and associated risk factors among female commercial sex workers in Cuautla, Morelos. Ginecol Obstet Mex 73:36-47.
2. Biernat-Sudolska M, Szostek S, Rojek-Zakrzewska D, Klimek M, Kosz-Vnenchak M. 2011. Concomitant infections with human papillomavirus and various mycoplasma and ureaplasma species in women with abnormal cervical cytology. Adv Med Sci 56:299-303.
3. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Munoz N. 2008. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 10:(26 Suppl) K1-16.
4. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. 2010. Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of one million women with normal cytological findings. J Infect Dis 202:1789-1799.
5. Carrillo-Garcia A, Ponce-de-Leon-Rosales S, Cantu-de-Leon D, Fragoso-Ontiveros V, Martinez-Ramirez I, Orozco-Colin A, Mohar A, Lizano M. 2014. Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer. Gynecol Oncol 134:534-539.
6. Castellsague X 2008. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 110:(3 Suppl 2) S4-S7.
7. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, Group IHPSS. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 366:991-998.
8. da Silva Barros NK, Costa MC, Alves RR, Villa LL, Derchain SF, Zeferino LC, Dos Santos Carneiro, Rabelo-Santos 2012. Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil. J Med Virol 84:1143-1150.
9. de Jesus De Haro-Cruz M, Deleon-Rodriguez I, Escobedo-Guerra MR, Lopez-Hurtado M, Arteaga-Troncoso G, Ortiz-Ibarra FJ, Guerra-Infante FM. 2011. Genotyping of Chlamydia trachomatis from endocervical specimens of infertile Mexican women. Enferm Infecc Microbiol Clin 29:102-108.
10. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX, Retrospective International S, Group HPVTTS. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 11:1048-1056.
11. Gao W, Weng J, Gao Y, Chen X. 2013. Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: A cross-sectional study. BMC Infect Dis 13:271.
12. Gonzalez-Pedraza A, Ortiz C, Mota R, Davila R, Dickinson E. 2003. Role of bacteria associated with sexually transmitted infections in the etiology of lower urinary tract infection in primary care. Enferm Infecc Microbiol Clin 21:89-92.
13. Gonzalez-Pedraza-Aviles A, Inzunza-Montiel A, Ortiz-Zaragoza C, Ponce-Rosas R, Irigoyen-Coria A. 1997. A comparison of 2 clinical laboratory methods in the diagnosis of bacterial vaginosis. Aten Primaria 19:357-360.
14. Hajikhani B, Motallebi T, Norouzi J, Bahador A, Bagheri R, Asgari S, Chamani-Tabriz L. 2013. Classical and molecular methods for evaluation of chlamydia trachomatis infection in women with tubal factor infertility. J Reprod Infertil 14:29-33.
15. Jalal H, Delaney A, Bentley N, Sonnex C, Carne CA. 2013. Molecular epidemiology of selected sexually transmitted infections. Int J Mol Epidemiol Genet 4:167-174.
16. Kawaguchi S, Shigehara K, Sasagawa T, Shimamura M, Nakashima T, Sugimoto K, Nakashima K, Furubayashi K, Namiki M. 2012. Liquid-based urine cytology as a tool for detection of human papillomavirus, Mycoplasma spp., and Ureaplasma spp. in men. J Clin Microbiol 50:401-406.
17. Kenyon C, Buyze J, Colebunders R. 2014. Classification of incidence and prevalence of certain sexually transmitted infections by world regions. Int J Infect Dis 18:73-80.
18. Kim Y, Kim J, Lee KA. 2014. Prevalence of sexually transmitted infections among healthy Korean women: Implications of multiplex PCR pathogen detection on antibiotic therapy. J Infect Chemother 20:74-76.
19. Kumar MM, Adurthi S, Ramachandran S, Mukherjee G, Joy O, Krishnamurthy H, Krishna S, Bafna UD, Uma DK, Jayshree RS. 2013. Toll-like receptors 7, 8, and 9 expression and function in primary human cervical cancer Langerhans cells: Evidence of anergy. Int J Gynecol Cancer 23:184-192.
20. Lahiri DK, Nurnberger JI, Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
21. Lindh M, Gorander S, Andersson E, Horal P, Mattsby-Balzer I, Ryd W. 2007. Real-time Taqman PCR targeting 14 human papilloma virus types. J Clin Virol 40:321-324.
22. Ling Z, Liu X, Chen X, Zhu H, Nelson KE, Xia Y, Li L, Xiang C. 2011. Diversity of cervicovaginal microbiota associated with female lower genital tract infections. Microb Ecol 61:704-714.
23. Lizano M, De la Cruz-Hernandez E, Carrillo-Garcia A, Garcia-Carranca A, Ponce de Leon-Rosales S, Duenas-Gonzalez A, Hernandez-Hernandez DM, Mohar A. 2006. Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol 102:230-235.
24. McIver CJ, Rismanto N, Smith C, Naing ZW, Rayner B, Lusk MJ, Konecny P, White PA, Rawlinson WD. 2009. Multiplex PCR testing detection of higher-than-expected rates of cervical mycoplasma, ureaplasma, and trichomonas and viral agent infections in sexually active australian women. J Clin Microbiol 47:1358-1363.
25. Meloni A, Pilia R, Campagna M, Usai A, Masia G, Caredda V, Coppola RC. 2014. Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities. J Public Health Res 3:157.
26. Mendoza L, Mongelos P, Paez M, Castro A, Rodriguez-Riveros I, Gimenez G, Araujo P, Echague G, Diaz V, Laspina F, Castro W, Jimenez R, Marecos R, Ever S, Deluca G, Picconi MA. 2013. Human papillomavirus and other genital infections in indigenous women from Paraguay: A cross-sectional analytical study. BMC Infect Dis 13:531.
27. Muller EE, Venter JM, Magooa MP, Morrison C, Lewis DA, Mavedzenge SN. 2012. Development of a rotor-gene real-time PCR assay for the detection and quantification of Mycoplasma genitalium. J Microbiol Methods 88:311-315.
28. Nees M, Geoghegan JM, Hyman T, Frank S, Miller L, Woodworth CD. 2001. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J Virol 75:4283-4296.
29. Oliveira FA, Lang K, Ehrig V, Heukelbach J, Fraga F, Stoffler-Meilicke M, Ignatius R, Franco Sansigolo Kerr LR, Feldmeier H. 2008. Risk factors for sexually transmitted infections in women in rural Northeast Brazil. J Infect Dev Ctries 2:211-217.
30. Paba P, Bonifacio D, Di Bonito L, Ombres D, Favalli C, Syrjanen K, Ciotti M. 2008. Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology 51:230-234.
31. Peralta-Rodriguez R, Romero-Morelos P, Villegas-Ruiz V, Mendoza-Rodriguez M, Taniguchi-Ponciano K, Gonzalez-Yebra B, Marrero-Rodriguez D, Salcedo M. 2012. Prevalence of human papillomavirus in the cervical epithelium of Mexican women: Meta-analysis. Infect Agents Cancer 7:34.
32. Shew ML, Ermel AC, Weaver BA, Tong Y, Tu W, Kester LM, Denski C, Fortenberry JD, Brown DR. 2013. Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance. J Infect Dis 208:1416-1421.
33. Shim HS, Noh S, Park AR, Lee YN, Kim JK, Chung HJ, Kang KS, Cho NH. 2010. Detection of sexually transmitted infection and human papillomavirus in negative cytology by multiplex-PCR. BMC Infect Dis 10:284.
34. Silva J, Cerqueira F, Ribeiro J, Sousa H, Osorio T, Medeiros R. 2013. Is Chlamydia trachomatis related to human papillomavirus infection in young women of southern European population? A self-sampling study. Arch Gynecol Obstet 288:627-633.
35. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr., Young N, Forum Group M, Bethesda W. 2002. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. Jama 287:2114-2119.
36. Tanzi E, Bianchi S, Fasolo MM, Frati ER, Mazza F, Martinelli M, Colzani D, Beretta R, Zappa A, Orlando G. 2013. High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping. J Med Virol 85:91-98.
37. Tena-Suck ML, Alarcon-Herrera A, Tirado-Sanchez A, Rosl F, Astudillo-de la Vega H. 2012. Male urethral Pap smears and peniscopy examination and polymerase chain reaction human papillomavirus correlation. Diagn Cytopathol 40:597-603.
38. Ursell LK, Gunawardana M, Chang S, Mullen M, Moss JA, Herold BC, Keller MJ, McDonald D, Gonzalez A, Knight R, Baum MM. 2014. Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings. Antiviral Res 102:87-94.
39. Verteramo R, Pierangeli A, Mancini E, Calzolari E, Bucci M, Osborn J, Nicosia R, Chiarini F, Antonelli G, Degener AM. 2009. Human Papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis 9:16.
40. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. 2007. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 370:1453-1457.
41. Wager E, Kleinert S. 2014. Responsible research publication: International standards for authors. Prilozi/Makedonska akademija na naukite i umetnostite, Oddelenie za bioloski i medicinski nauki=Contributions/Macedonian Academy of Sciences and Arts. Section Biol Med Sci 35:29-33.
42. Wangnapi RA, Soso S, Unger HW, Sawera C, Ome M, Umbers AJ, Ndrewei N, Siba P, Li Wai Suen CS, Vallely A, Wapling J, Ryan C, Mueller I, Rogerson SJ. 2015. Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New Guinea. Sex Transm Infect 91:194-200.
43. Weissenbacher T, Walter C, Mylonas I, Scholz C, Gingelmaier A, Friese K. 2010. Interleukin-6, interleukin-10 and interleukin-12 in vaginal fluid from women with bacterial vaginosis. Arch Gynecol Obstet 281:77-80.
44. Woo YL, van den Hende M, Sterling JC, Coleman N, Crawford RA, Kwappenberg KM, Stanley MA, van der Burg SH. 2010. A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses. Int J Cancer 126:133-141.
45. Zhou F, Chen J, Zhao KN. 2013. Human papillomavirus 16-encoded E7 protein inhibits IFN-gamma-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes. J Gen Virol 94: (Pt 11) 2504-2514.
46. Zhou F, Leggatt GR, Frazer IH. 2011. Human papillomavirus 16 E7 protein inhibits interferon-gamma-mediated enhancement of keratinocyte antigen processing and T-cell lysis. FEBS J 278:955-963.